Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Active, not recruiting · NCT05787821
Conditions: Knee Pain Chronic, Osteoarthritis, Knee, Rheumatoid Arthritis, Traumatic Arthritis, Polyarthritis, Varus Deformity, Valgus Deformity, Flexion Deformity of Knee, Avascular Necrosis
At a glance
- Research payments reported, 2025
- $37,768
- U.S. investigators named
- 2
- Sites paid
- 3
- Planned or actual enrollment
- 760
About the trial
- Sponsor
- Zimmer Biomet
- Tested
- Total Knee Arthroplasty (device)
- Dates
- Started 2023-06-28; completion 2035-06
- Results posted
- Not yet
The main objective of the study is to evaluate the safety, performance and clinical benefits of the Persona implant and its instrumentation in primary total knee arthroplasty
From ClinicalTrials.gov, last updated 2026-10-19. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Zimmer Biomet Holdings, Inc. reported $37,768 in research payments for this study in 2025 (10 payments).
Products named: Persona
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Brian T. Palumbo, MD Orthopedic Surgery · Temple Terrace, FL
- George N. Guild III, M.D. Orthopedic Surgery · Cumming, GA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Northside Hospital, Inc $30,586
- Foundation for Orthopaedic Research & Ed $3,704
- Wcg Irb $3,478
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.